Research News
The GW Postdoctoral Primary Care Research Training Program (P-CART) is currently accepting applications for immediate and July 2022 appointments.
A $1 million gift from Ulvi M. and Reykhan Kasimov seeks to advance development of a new technique that uses RNA transcript levels to identify biomarkers in the blood stream, which can help detect active infections in the body.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) and the GW Medical Faculty Associates (MFA) have established a new, centralized Office of Clinical Research (OCR) that will serve as a go-to resource for all faculty and staff involved in clinical research at the…
Katherine Blackmore, PhD ’21, received a 2021 Chorafas Foundation Award for outstanding work in the selected fields of engineering sciences, medicine, and natural sciences for her work on metabolic syndrome.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) was recently awarded a National Institutes of Health (NIH) T-32 research training grant. The five-year grant, worth nearly $1 million overall, will support the training of junior scientists who will advance research…
In a recent study, Tim McCaffrey, PhD, professor of medicine at the George Washington University School of Medicine and Health Sciences, led a team of researchers conducting the largest RNA expression analysis of human coronary artery disease to date.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced that Robert H. Miller, PhD, will serve as the vice dean for research and academic affairs, effective Aug. 1, 2021. Miller has been serving on an interim basis in this role since early 2020.
Anne Chiaramello, PhD, associate professor of anatomy and cell biology and founding director of the Mito-EpiGen Program, discusses the $1.13 million NIH grant she is working on with Andrea Gropman, MD, from Children’s National Hospital, to test a novel therapeutic approach for two rare…
The George Washington University School of Medicine and Health Sciences researchers have been awarded a $3.6 million contract to genetically modify commensal organisms to produce antidotes for harmful biological and chemical agents, such as anthrax, Ebola, and even COVID-19.
A vaccine for Lassa fever may be on the horizon, thanks to a new clinical trial jointly led by Elissa Malkin, DO, MPH, assistant research professor of medicine at the George Washington University School of Medicine and Health Sciences.